ticlopidine has been researched along with Dysmyelopoietic Syndromes in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M | 1 |
| Chen, T | 1 |
| Liang, C | 1 |
| Xiang, X | 1 |
| He, Z | 1 |
| Wu, Z | 1 |
| Wercules, O | 1 |
| Meireles, GC | 1 |
| Longhi, A | 1 |
| Beltrão, P | 1 |
| Pimenta, J | 1 |
2 other studies available for ticlopidine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Myelodysplastic syndrome associated with clopidogrel: a case report.
Topics: Aged; Clopidogrel; Female; Humans; Myelodysplastic Syndromes; Platelet Aggregation Inhibitors; Ticlo | 2012 |
In-hospital and late outcomes after coronary stenting in patient with unstable angina and myelodysplastic syndrome.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Humans; Male; M | 2006 |